Women's Imaging

Time magazine compiled its list of last year’s remarkable healthcare innovations and achievements, and No. 1 was 3D mammography, or tomosynthesis.

Vox Media picked up on the story of the first birth captured on MRI, and the images are available for anyone to view.

Ultrasound boutiques offering elective ultrasounds for expectant mothers seems like a harmless bit of fun for parents looking to collect images or video of their child before they are even born, but the FDA and others are not as amused.

With the high political contention that surrounds the Affordable Care Act (ACA), it’s no surprise that numerous rumors have been circulating about what types of care and procedures are and are not covered under the statute. In particular, many believe that the ACA restricts one’s ability to get a mammogram. FactCheck.org recently debunked this myth, addressing the growing concern that women over the age of 70 will not be covered by Obamacare for mammography.

In the latest “Medical Edge Newspaper Column” from the Mayo Clinic, Stephanie Hines, MD, of Mayo’s Breast Clinic in Jacksonville, Fla., responds to a question about why mammography is the recommended first test in breast cancer screening over MRI. The article offers a quick refresher on the basics of how the two modalities are used to screen for breast cancer.

With Breast Cancer Awareness Month in full swing, it’s become increasingly difficult to overlook the plea of the pink. However, the complexity behind the decision to undergo mammography screening is lost on many, leaving women vulnerable to overdiagnosis and other potential health risks.

One of the major issues with breast cancer screening is reducing the number of false positives, as they can lead to expensive and potentially harmful downstream testing. A new screening technique being developed by a joint Brigham Young University and University of Utah research team aims to solve this issue.

As organizations continue to debate the optimal recommendations for mammogram screening guidelines, it is easy for certain myths to take root in the public consciousness.

The lay media often cast the screening mammo debate in black and white terms. It’s a disservice; breast imagers and physicians realize the issues are far more nuanced. Women’s right to screening is a highly emotionally charged issue, further complicating physicians’ attempts to educate women and often derailing stakeholders’ calls for targeted screening. Peggy Orenstein completed an incredibly detailed review of the risks and benefits of screening and treatment and the role of nonprofit marketing in an article published April 26 in The New York Times magazine. Check it out, and please consider sharing it.